Literature DB >> 8304536

Inhibition of nitric oxide synthesis suppresses sleep in rabbits.

L Kapás1, M Shibata, M Kimura, J M Krueger.   

Abstract

The effects of N omega-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthesis, on spontaneous and interleukin-1 (IL-1)-induced sleep were examined in rabbits. Animals were injected intracerebroventricularly or intravenously during the light phase with vehicle, L-NAME, IL-1, or the combination of L-NAME and IL-1. Injection of L-NAME (5 mg icv and 100 mg/kg iv) suppressed both non-rapid eye movement sleep (NREMS) and rapid eye movement sleep (REMS) for 4-6 h. The sleep-suppressive effects are unlikely due to pressor responses to L-NAME because administration of L-NAME (5 mg icv) produced only a transient (3-4 min) slight increase in systemic blood pressure. Injection of IL-1 (20 ng icv) elicited fever, suppressed REMS, and increased NREMS for 6 h. NREMS was suppressed for 3 h after the combined intracerebroventricular injections of 5 mg L-NAME and 20 ng IL-1 and was elevated during postinjection hours 4-6. Administration of IL-1 (30 ng/kg iv) increased NREMS and brain temperature for 2 h. After the combined injection of IL-1 and L-NAME (100 mg/kg), NREMS was significantly suppressed during postinjection hours 1-5. It is not known whether the interactions between the sleep-suppressive effects of L-NAME and the NREMS-promoting effects of IL-1 are specific, being mediated via a common mechanism, or whether they are additive, being mediated via independent mechanisms. The pyrogenic and REMS-suppressive actions of either intracerebroventricularly or intravenously injected IL-1 were not affected by L-NAME.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304536     DOI: 10.1152/ajpregu.1994.266.1.R151

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons.

Authors:  Anna V Kalinchuk; Robert W McCarley; Tarja Porkka-Heiskanen; Radhika Basheer
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

3.  Nitric oxide-stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity.

Authors:  P A Rosenberg; Y Li; M Le; Y Zhang
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Nitric oxide production in the perifornical-lateral hypothalamic area and its influences on the modulation of perifornical-lateral hypothalamic area neurons.

Authors:  A Kostin; S Rai; S Kumar; R Szymusiak; D McGinty; M N Alam
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

5.  SLEEP AND CYTOKINES.

Authors:  James M Krueger; David M Rector; Lynn Churchill
Journal:  Sleep Med Clin       Date:  2007

Review 6.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

7.  TRANSLATION OF BRAIN ACTIVITY INTO SLEEP.

Authors:  James M Krueger
Journal:  Hirosaki Igaku       Date:  2012

Review 8.  Cytokines in immune function and sleep regulation.

Authors:  James M Krueger; Jeannine A Majde; David M Rector
Journal:  Handb Clin Neurol       Date:  2011

9.  Febrigenic signaling to the brain does not involve nitric oxide.

Authors:  Alexandre A Steiner; Alla Y Rudaya; Andrei I Ivanov; Andrej A Romanovsky
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

10.  Differential effects of paradoxical sleep deprivation on memory and oxidative stress.

Authors:  Alisson Menezes Araujo Lima; Veralice Meireles Sales de Bruin; Emiliano Ricardo Vasconcelos Rios; Pedro Felipe Carvalhedo de Bruin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.